The call, meant to make the benchmark better represent the economy, has left investors tracking the average with less money than they would have had otherwise.
The Dow Jones Industrial Average faltered Thursday thanks in large part to a massive selloff for software giant Salesforce, as rosy artificial intelligence dreams have proven unable to support the blue chip stock index's record highs.
Zoetis is the clear leader in the global animal healthcare industry. Its newest osteoarthritis medications are seeing early success.
Despite stocks markets rebounding in Europe, Wall Street equity futures indicated a lower start amid a swathe of retail sector earnings. Dow Jones futures pointed to a decline of 0.9%, with S&P 500 futures down 0.4% and those for the Nasdaq 100 falling 0.3%.
S&P 500 ends three-day winning streak, Salesforce plunges on revenue and forecast and Peltz sells entire Disney stake.
ConocoPhillips is set to buy Marathon Oil in a $17 billion deal that would boost its portfolio.
In the closing of the recent trading day, Dow Inc. (DOW) stood at $57, denoting a -1.79% change from the preceding trading day.
The main indexes pulled back Wednesday with health insurer UnitedHealth creating the biggest drag on the blue chip Dow.
The index has tumbled about 1,500 points, or 3.7%, in just a little less than two weeks, while the rest of the stock market is holding its ground.
There's a reason JPMorgan Chase stock is rallying when it seems like it shouldn't be. Software giant Microsoft is evolving its business model to one that generates recurring revenue.
Dow Jones tech giant Apple stock and AI Leader CrowdStrike are approaching new buy points in today's stock market.